Show simple item record

dc.contributor.authorAssemblée mondiale de la Santé, 31
dc.date.accessioned2015-10-21T15:15:22Z
dc.date.available2015-10-21T15:15:22Z
dc.date.issued1978
dc.identifier.govdocA31/67
dc.identifier.urihttp://www.who.int/iris/handle/10665/190056
dc.language.isofren_US
dc.publisherOrganisation mondiale de la Santéen_US
dc.subjectPharmaceutical productsen_US
dc.subjectEssencial medicinesen_US
dc.subject.meshWorld Health Organizationen_US
dc.subject.meshProgram Developmenten_US
dc.subject.meshFinancial Managementen_US
dc.subject.meshBudgetsen_US
dc.subject.meshPharmaceutical Preparationsen_US
dc.subject.meshDrugs, Essentialen_US
dc.subject.meshDrug and Narcotic Controlen_US
dc.subject.meshHealth Services Researchen_US
dc.subject.meshBiomedical Technologyen_US
dc.subject.meshPlants, Medicinalen_US
dc.titleTroisième rapport de la Commission A (‎projet)‎en_US
dc.typeGoverning body documentsen_US
dc.subject.meshqualifierstatistics and numerical dataen_US
dc.subject.meshqualifierprevention and controlen_US


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record